[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100623565":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":35,"locations":41,"responsibleParty":70,"collaborators":72,"id":79,"slug":80,"hasResults":81,"nctId":82,"briefTitle":83,"officialTitle":84,"acronym":85,"eligibilityCriteria":86,"healthyVolunteers":81,"sex":87,"minAge":88,"maxAge":26,"enrollmentInfo":89,"targetDuration":26,"studyType":92,"phases":93,"briefSummary":95,"conditions":96,"keywords":98,"overallStatus":44,"whyStopped":26,"lastUpdateSubmitDate":104,"lastUpdatePostDateStruct":105,"startDateStruct":108,"completionDateStruct":110,"leadSponsor":112,"locationsCount":113},{"fullName":5,"class":6},"Region Skane","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"L-Menthol","EXPERIMENTAL","In the trial, prior to performing submaximal cardio-pulmonary exercise testing (CPET), participants will be administered, L-menthol patch which will be attached to the inside of a facemask that is connected to the breathing circuit.",[13],"Drug: L-menthol",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","For placebo, the patch will contain a similarly patch with strawberry scent.",[19],"Other: Placebo",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","L-menthol","(Sigma-Aldrich, St. Louis, US)",[9],null,{"type":6,"name":15,"description":28,"armGroupLabels":29,"otherNames":26},"Strawberry scent (Sigma-Aldrich, St. Louis, US)",[15],[31],{"name":32,"affiliation":33,"role":34},"Zainab Ahmadi","Region Skåne and Lund University","PRINCIPAL_INVESTIGATOR",[36],{"name":37,"role":38,"phone":39,"phoneExt":26,"email":40},"Zainab Ahmadi, MD, PhD","CONTACT","046171000","zainab.ahmadi@med.lu.se",[42,60],{"facility":43,"status":44,"city":45,"state":46,"zip":26,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Blekinge Institute of Technology","RECRUITING","Karlskrona","Blekinge County","Sweden","SE",{"type":50,"coordinates":51},"Point",[52,53],15.58661,56.16156,{"lat":53,"lon":52},[56],{"name":57,"role":38,"phone":58,"phoneExt":26,"email":59},"Jacob Sandberg, MD, PhD","+46 (0)455-38 54 09","jacob.sandberg@bth.se",{"facility":61,"status":44,"city":62,"state":26,"zip":26,"country":47,"countryCode":48,"cosmosGeoPoint":63,"geoPoint":67,"contacts":68},"Lund University hospital and Region Skåne","Lund",{"type":50,"coordinates":64},[65,66],13.19321,55.70584,{"lat":66,"lon":65},[69],{"name":37,"role":38,"phone":39,"phoneExt":26,"email":40},{"type":71,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR",[73,74,77],{"name":43,"class":6},{"name":75,"class":76},"Blekingesjukhuset, Karlskrona","UNKNOWN",{"name":78,"class":6},"Lund University","100623565","phase-2-efficacy-of-l-menthol-on-breathlessness-in-interstitial-lung-disease-100623565",false,"NCT07398287","Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease","Effect of L-menthol on Breathlessness and Exercise Capacity in Interstitial Lung Disease: a Randomized Crossover Trial","Ment-ILD","Inclusion Criteria:\n\n* The subject has given written consent to participate in the study\n* Physician diagnosis of fibrosing ILD according to international guidelines\n* age 18 years or older\n* able to cycle\n* able to understand and talk Swedish to participate in the study procedures, as judged by the Investigators.\n\nExclusion Criteria:\n\n* Resting peripheral oxygen saturation (SpO2) \\\u003C 92%\n* hospitalization or clinical instability during the last four weeks\n* treatment with supplementary oxygen at rest or during exercise\n* contraindication to exercise testing in accordance with clinical practice guidelines\n* expected survival shorter than six months as judged by the Investigator\n* medical conditions including congestive heart failure, acute coronary artery disease, neuromuscular diseases, severe psychiatric illness, and olfaction disorder.","ALL","18 Years",{"count":90,"type":91},20,"ESTIMATED","INTERVENTIONAL",[94],"PHASE2","The purpose of this study is to assess the effect of L-menthol on breathlessness and exercise capacity in patients with Interstitial lung disease (ILD).",[97],"Interstitial Lung Disease (ILD)",[99,100,101,102,103],"interstitial lung disease","breathlessness","dyspnea","CPET","exercise","2026-04-23",{"date":106,"type":107},"2026-04-24","ACTUAL",{"date":109,"type":107},"2026-04-13",{"date":111,"type":91},"2027-05",{"name":5,"class":6},2]